Amphastar Pharmaceuticals, Inc. (AMPH)
27.65
+0.10
(+0.36%)
USD |
NASDAQ |
Feb 24, 16:00
27.65
0.00 (0.00%)
After-Hours: 18:49
Amphastar Pharmaceuticals Research and Development Expense (Quarterly) : 18.73M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.802B |
| Pfizer Inc. | 3.206B |
| Organon & Co. | 91.00M |
| Catalyst Pharmaceuticals, Inc. | 2.657M |
| CorMedix, Inc. | 5.098M |